Michel Vidal
Michel Vidal (October 1, 1824 - October 20, 1895) was a U.S. Representative from Louisiana.Born in the city of Carcassonne, Languedoc, France, Vidal completed university-level studies in France before emigrating to the Republic of Texas. Soon after Texas became annexed to the United States, Vidal moved to the French-speaking region of south Louisiana. He engaged in literary and scientific pursuits and served as associate editor of several American and French newspapers for the French-speaking populations of the U.S. and Canada. He also served as an editor of the ''New York Courrier des États-Unis'' and the New Orleans ''Picayune'' (now the ''Times-Picayune''). At the close of the Civil War he was appointed by General John T. Sheridan a registrar for the city of New Orleans. In 1867, he moved to Opelousas, Louisiana, where he founded and edited the ''Saint Landry Progress''. He served as delegate to the State constitutional convention of 1867 and 1868 (this convention wrote the "Reconstruction Constitution" which was in turn rescinded after white Democrats again gained control of Louisiana government) after 1876.
Upon readmission of Louisiana to representation in Congress, Vidal was elected, from Louisiana's 4th congressional district (which included Opelousas), as a Republican to the Fortieth United States Congress, (July 18, 1868 – March 3, 1869), and was effectively in office until 1870. He was appointed a United States commissioner under the convention concluded with Peru in 1868 for the adjustment of claims of citizens of either country. On his leaving Congress, Vidal was appointed by President Ulysses Grant as United States consul at Tripoli, Libya, where he served from April 5, 1870, to October 12, 1876. He died in Montreal. Provided by Wikipedia
Showing 1 - 16 results of 16 for search 'Michel Vidal', query time: 0.05s
Refine Results
-
1
Le sens corporel à l’égard d’une question socialement vive, une source d’apprentissage by Michel Vidal
Published 2022-12-01
Article -
2
-
3
-
4
-
5
-
6
O USO DO TEATRO DE FANTOCHES SOBRE AS REGIÕES BRASILEIRAS NAS AULAS DE GEOGRAFIA DO ENSINO FUNDAMENTAL: UMA EXPERIÊNCIA DO PIBID/GEOGRAFIA/UFSM 2018 by Natália Lampert Batista, Renata Carvalho Arruda, Michel Vidal Simões, Larissa Bassan, Maurício Pase Leite
Published 2019-07-01
Article -
7
-
8
-
9
Shifting the paradigm: the putative mitochondrial protein ABCB6 resides in the lysosomes of cells and in the plasma membrane of erythrocytes. by Katalin Kiss, Anna Brozik, Nora Kucsma, Alexandra Toth, Melinda Gera, Laurence Berry, Alice Vallentin, Henri Vial, Michel Vidal, Gergely Szakacs
Published 2012-01-01
Article -
10
-
11
Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. by Olivier Mir, Romain Coriat, Benoit Blanchet, Jean-Philippe Durand, Pascaline Boudou-Rouquette, Judith Michels, Stanislas Ropert, Michel Vidal, Stanislas Pol, Stanislas Chaussade, François Goldwasser
Published 2012-01-01
Article -
12
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab by Gaëlle Noé, Audrey Bellesoeur, Lisa Golmard, Audrey Thomas-Schoemann, Pascaline Boudou-Rouquette, Manuela Tiako Meyo, Alicja Puszkiel, Jennifer Arrondeau, Jérome Alexandre, François Goldwasser, Benoit Blanchet, Michel Vidal
Published 2019-05-01
Article -
13
Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A. by Jean-François Gaucher, Marie Reille-Seroussi, Nathalie Gagey-Eilstein, Sylvain Broussy, Pascale Coric, Bili Seijo, Marie-Bernard Lascombe, Benoit Gautier, Wang-Quing Liu, Florent Huguenot, Nicolas Inguimbert, Serge Bouaziz, Michel Vidal, Isabelle Broutin
Published 2016-01-01
Article -
14
Exposure–Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer by Thomas Rodier, Alicja Puszkiel, Evelina Cardoso, David Balakirouchenane, Céline Narjoz, Jennifer Arrondeau, Vincent Fallet, Nihel Khoudour, Monia Guidi, Michel Vidal, Xavier Declèves, Chantal Csajka, Jérôme Alexandre, Jacques Cadranel, Elizabeth Fabre, Marie Wislez, François Goldwasser, Benoit Blanchet
Published 2022-09-01
Article -
15
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study by Manuela Tiako Meyo, Anne Jouinot, Etienne Giroux-Leprieur, Elizabeth Fabre, Marie Wislez, Marco Alifano, Karen Leroy, Pascaline Boudou-Rouquette, Camille Tlemsani, Nihel Khoudour, Jennifer Arrondeau, Audrey Thomas-Schoemann, Hélène Blons, Audrey Mansuet-Lupo, Diane Damotte, Michel Vidal, François Goldwasser, Jérôme Alexandre, Benoit Blanchet
Published 2020-02-01
Article -
16
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma by David Balakirouchenane, Sarah Guégan, Chantal Csajka, Anne Jouinot, Valentine Heidelberger, Alicja Puszkiel, Ouidad Zehou, Nihel Khoudour, Perrine Courlet, Nora Kramkimel, Coralie Lheure, Nathalie Franck, Olivier Huillard, Jennifer Arrondeau, Michel Vidal, Francois Goldwasser, Eve Maubec, Nicolas Dupin, Selim Aractingi, Monia Guidi, Benoit Blanchet
Published 2020-04-01
Article